Tags

Type your tag names separated by a space and hit enter

[Stereotactic vacuum-assisted breast biopsy--success, histologic accuracy, patient acceptance and optimizing the BI-RADSTM-correlated indication].
Rofo. 2003 Jan; 175(1):99-104.ROFO

Abstract

PURPOSE

To evaluate success, histologic accuracy, patient acceptance and BI-RADS TM-correlated malignancy rate of stereotactic vacuum-assisted breast biopsies in order to optimize the indication.

MATERIALS AND METHODS

In 132 patients with mammographically detected breast lesions 166 stereotactic vacuum- assisted 11 gauge core biopsies were performed. All lesions were classified according to the BI-RADS TM categories of the ACR. Removal of the lesion was radiographically assessed as complete, representative or not representative. Patient acceptance was evaluated.

RESULTS

Of the 166 lesions, 54 (32.5 %) lesions were judged completely removed, 110 (66.3 %) representatively removed and 2 (1.2 %) not representatively removed. Malignancy was found in 38 (22.9 %) lesions. The rate of malignancy increased from 6.3 % (2/32) for BI-RADS TM category 3 to 16.7 % (19/114) for BI-RADS TM category 4 and increased further to 85 % (17/20) for BI-RADS TM category 5 (p < 0.001). The histology of a sufficient vacuum-assisted biopsy was underestimated in 6 (15 %) of the 40 lesions that were subsequently excised surgically. Most patients (98.5 %; 130/132) stated they would undergo a vacuum-assisted biopsy again.

CONCLUSION

Vacuum-assisted breast biopsy is accurate, has a justifiable rate of histologic underestimation and is well accepted by patients. Patients with BI-RADS TM category 4 microcalcification benefit the most. Lesions of BI-RADS TM category 3 and BI-RADS TM category 5 should be biopsied only under special circumstances (family risk of breast cancer; assessment of lesions extension).

Authors+Show Affiliations

Abteilung Radiologische Diagnostik, Universitätsklinik Tübingen, Germany. katja.siegmann@med.uni-tuebingen.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Evaluation Study
Journal Article

Language

ger

PubMed ID

12525989

Citation

Siegmann, K C., et al. "[Stereotactic Vacuum-assisted Breast Biopsy--success, Histologic Accuracy, Patient Acceptance and Optimizing the BI-RADSTM-correlated Indication]." RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, vol. 175, no. 1, 2003, pp. 99-104.
Siegmann KC, Wersebe A, Fischmann A, et al. [Stereotactic vacuum-assisted breast biopsy--success, histologic accuracy, patient acceptance and optimizing the BI-RADSTM-correlated indication]. Rofo. 2003;175(1):99-104.
Siegmann, K. C., Wersebe, A., Fischmann, A., Fersis, N., Vogel, U., Claussen, C. D., & Müller-Schimpfle, M. (2003). [Stereotactic vacuum-assisted breast biopsy--success, histologic accuracy, patient acceptance and optimizing the BI-RADSTM-correlated indication]. RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, 175(1), 99-104.
Siegmann KC, et al. [Stereotactic Vacuum-assisted Breast Biopsy--success, Histologic Accuracy, Patient Acceptance and Optimizing the BI-RADSTM-correlated Indication]. Rofo. 2003;175(1):99-104. PubMed PMID: 12525989.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Stereotactic vacuum-assisted breast biopsy--success, histologic accuracy, patient acceptance and optimizing the BI-RADSTM-correlated indication]. AU - Siegmann,K C, AU - Wersebe,A, AU - Fischmann,A, AU - Fersis,N, AU - Vogel,U, AU - Claussen,C D, AU - Müller-Schimpfle,M, PY - 2003/1/15/pubmed PY - 2003/2/25/medline PY - 2003/1/15/entrez SP - 99 EP - 104 JF - RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin JO - Rofo VL - 175 IS - 1 N2 - PURPOSE: To evaluate success, histologic accuracy, patient acceptance and BI-RADS TM-correlated malignancy rate of stereotactic vacuum-assisted breast biopsies in order to optimize the indication. MATERIALS AND METHODS: In 132 patients with mammographically detected breast lesions 166 stereotactic vacuum- assisted 11 gauge core biopsies were performed. All lesions were classified according to the BI-RADS TM categories of the ACR. Removal of the lesion was radiographically assessed as complete, representative or not representative. Patient acceptance was evaluated. RESULTS: Of the 166 lesions, 54 (32.5 %) lesions were judged completely removed, 110 (66.3 %) representatively removed and 2 (1.2 %) not representatively removed. Malignancy was found in 38 (22.9 %) lesions. The rate of malignancy increased from 6.3 % (2/32) for BI-RADS TM category 3 to 16.7 % (19/114) for BI-RADS TM category 4 and increased further to 85 % (17/20) for BI-RADS TM category 5 (p < 0.001). The histology of a sufficient vacuum-assisted biopsy was underestimated in 6 (15 %) of the 40 lesions that were subsequently excised surgically. Most patients (98.5 %; 130/132) stated they would undergo a vacuum-assisted biopsy again. CONCLUSION: Vacuum-assisted breast biopsy is accurate, has a justifiable rate of histologic underestimation and is well accepted by patients. Patients with BI-RADS TM category 4 microcalcification benefit the most. Lesions of BI-RADS TM category 3 and BI-RADS TM category 5 should be biopsied only under special circumstances (family risk of breast cancer; assessment of lesions extension). SN - 1438-9029 UR - https://www.unboundmedicine.com/medline/citation/12525989/[Stereotactic_vacuum_assisted_breast_biopsy__success_histologic_accuracy_patient_acceptance_and_optimizing_the_BI_RADSTM_correlated_indication]_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2003-36600 DB - PRIME DP - Unbound Medicine ER -